Eleonora Lai

1.4k total citations
46 papers, 572 citations indexed

About

Eleonora Lai is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Eleonora Lai has authored 46 papers receiving a total of 572 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 14 papers in Pulmonary and Respiratory Medicine and 11 papers in Cancer Research. Recurrent topics in Eleonora Lai's work include Pancreatic and Hepatic Oncology Research (7 papers), Cancer Genomics and Diagnostics (7 papers) and Hepatocellular Carcinoma Treatment and Prognosis (7 papers). Eleonora Lai is often cited by papers focused on Pancreatic and Hepatic Oncology Research (7 papers), Cancer Genomics and Diagnostics (7 papers) and Hepatocellular Carcinoma Treatment and Prognosis (7 papers). Eleonora Lai collaborates with scholars based in Italy, United States and Belgium. Eleonora Lai's co-authors include Mario Scartozzi, Clelia Donisi, Nicole Liscia, Andrea Pretta, Pina Ziranu, Marco Puzzoni, Clelia Madeddu, Stefano Mariani, Antonio Macciò and Mara Persano and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Eleonora Lai

42 papers receiving 562 citations

Peers

Eleonora Lai
Guanghai Dai China
Andrea Pretta Italy
Xiaochun Zhang China
Hong Shen China
Clelia Donisi Italy
Yongsheng Yang China
Marco Seehawer United States
Yihua Huang China
Guanghai Dai China
Eleonora Lai
Citations per year, relative to Eleonora Lai Eleonora Lai (= 1×) peers Guanghai Dai

Countries citing papers authored by Eleonora Lai

Since Specialization
Citations

This map shows the geographic impact of Eleonora Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eleonora Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eleonora Lai more than expected).

Fields of papers citing papers by Eleonora Lai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eleonora Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eleonora Lai. The network helps show where Eleonora Lai may publish in the future.

Co-authorship network of co-authors of Eleonora Lai

This figure shows the co-authorship network connecting the top 25 collaborators of Eleonora Lai. A scholar is included among the top collaborators of Eleonora Lai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eleonora Lai. Eleonora Lai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lai, Eleonora, et al.. (2025). Liquid biopsy: An innovative tool in oncology. Where do we stand?. Seminars in Oncology. 52(2). 152343–152343. 2 indexed citations
3.
Madeddu, Clelia, Eleonora Lai, Manuela Neri, et al.. (2025). Association Between TP53 Mutations and Platinum Resistance in a Cohort of High-Grade Serous Ovarian Cancer Patients: Novel Implications for Personalized Therapeutics. International Journal of Molecular Sciences. 26(5). 2232–2232. 2 indexed citations
4.
Bonci, Eduard-Alexandru, et al.. (2025). Artificial intelligence in NSCLC management for revolutionizing diagnosis, prognosis, and treatment optimization: A systematic review. Critical Reviews in Oncology/Hematology. 216. 104929–104929. 1 indexed citations
5.
Ziranu, Pina, Andrea Pretta, Flaviana Cau, et al.. (2024). CD44: A New Prognostic Marker in Colorectal Cancer?. Cancers. 16(8). 1569–1569. 16 indexed citations
6.
Madeddu, Clelia, Giulia Gramignano, Eleonora Lai, et al.. (2024). Leptin as a surrogate immune-metabolic marker to predict impact of anti-cachectic therapy: results of a prospective randomized trial in multiple solid tumors. ESMO Open. 9(10). 103738–103738. 1 indexed citations
7.
Prince, David, Eleonora Lai, Miriam Levy, et al.. (2024). The Liver Frailty Index predicts survival in systemic therapy for hepatocellular carcinoma: a multicentre prospective cohort study. SHILAP Revista de lepidopterología. 3. 100043–100043. 1 indexed citations
8.
Ziranu, Pina, Andrea Pretta, Raffaele Murru, et al.. (2023). New Horizons in Metastatic Colorectal Cancer: Prognostic Role of CD44 Expression. Cancers. 15(4). 1212–1212. 9 indexed citations
9.
Dessì, Mariele, Pina Ziranu, Clelia Madeddu, et al.. (2023). 349P The influence of diabetes on taxane-induced neurotoxicity and quality of life in breast cancer patients. Annals of Oncology. 34. S321–S321. 1 indexed citations
10.
Porcu, Cristina, Eleonora Lai, Andrea Bellodi, et al.. (2022). Investigating the Ovarian Microstructure in the Genera Helicolenus and Scorpaena (Teleostei, Sub-Order Scorpaenoidei) with Implications for Ovarian Dynamics and Spawning. Animals. 12(11). 1412–1412. 4 indexed citations
11.
Pretta, Andrea, Pina Ziranu, Riccardo Giampieri, et al.. (2022). Influence of antidiabetic drugs on glucose metabolism and immune response in patients with metastatic pancreatic ductal adenocarcinoma receiving gemcitabine plus nab-paclitaxel as first-line treatment. Digestive and Liver Disease. 55(5). 655–660. 2 indexed citations
12.
Massa, Elena, Clelia Donisi, Nicole Liscia, et al.. (2021). The Difficult Task of Diagnosing Depression in Elderly People with Cancer: A Systematic Review. Clinical Practice and Epidemiology in Mental Health. 17(1). 295–306. 2 indexed citations
13.
Pretta, Andrea, Clelia Donisi, Mara Persano, et al.. (2021). P-128 Influence of anti-diabetic medications on the outcomes of patients with pancreatic ductal adenocarcinoma and type 2 diabetes mellitus. Annals of Oncology. 32. S142–S142. 1 indexed citations
14.
Lai, Eleonora, Stefano Cascinu, & Mario Scartozzi. (2021). Are All Anti-Angiogenic Drugs the Same in the Treatment of Second-Line Metastatic Colorectal Cancer? Expert Opinion on Clinical Practice. Frontiers in Oncology. 11. 637823–637823. 9 indexed citations
15.
Lai, Eleonora, Marco Puzzoni, Pina Ziranu, et al.. (2021). Long Term Survival With Regorafenib: REALITY (Real Life in Italy) Trial - A GISCAD Study. Clinical Colorectal Cancer. 20(4). e253–e262. 2 indexed citations
16.
Vega-Benedetti, Ana Florencia, Eleonora Loi, Loredana Moi, et al.. (2020). Colorectal Cancer Early Detection in Stool Samples Tracing CpG Islands Methylation Alterations Affecting Gene Expression. International Journal of Molecular Sciences. 21(12). 4494–4494. 25 indexed citations
17.
Faloppi, Luca, Marco Puzzoni, Andrea Casadei‐Gardini, et al.. (2020). Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE-2 Study. Targeted Oncology. 15(1). 115–126. 14 indexed citations
18.
Casadei‐Gardini, Andrea, Giulia Rovesti, Vincenzo Dadduzio, et al.. (2020). Impact of Aspirin on clinical outcome in advanced HCC patients receiving sorafenib and regorafenib. HPB. 23(6). 915–920. 16 indexed citations
19.
Lai, Eleonora, Marco Puzzoni, Pina Ziranu, et al.. (2019). New therapeutic targets in pancreatic cancer. Cancer Treatment Reviews. 81. 101926–101926. 76 indexed citations
20.
Astara, Giorgio, Eleonora Lai, Mariele Dessì, et al.. (2017). Medical management of malignant bowel obstruction: our center experience. Annals of Oncology. 28. vi15–vi15. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guanghai Dai Breakdown of academic impact, for papers by Andrea Pretta Breakdown of academic impact, for papers by Xiaochun Zhang Breakdown of academic impact, for papers by Hong Shen Breakdown of academic impact, for papers by Clelia Donisi Breakdown of academic impact, for papers by Yongsheng Yang Breakdown of academic impact, for papers by Marco Seehawer Breakdown of academic impact, for papers by Yihua Huang
Rankless by CCL
2026